Related Experiment Video
Updated: Jun 17, 2026
Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
Published on: March 22, 2024
Simvastatin reduces mortality and hepatic injury after hemorrhage/resuscitation in rats
Borna Relja1, Mark Lehnert, Korbinian Seyboth
1Departments of Trauma SurgeryJohann Wolfgang Goethe University Frankfurt am Main, Frankfurt, Germany.
Insights
Simvastatin pretreatment significantly improves survival and reduces liver injury following hemorrhage/resuscitation in rats. This protective effect is linked to reduced inflammation and oxidative stress, highlighting statins
Area of Science:
- Biomedical Science
- Pharmacology
- Inflammation Research
Background:
- Statins are known for lowering cholesterol by inhibiting HMG-CoA reductase.
- Emerging evidence suggests statins possess cholesterol-independent effects, modulating proteins like Rho/Rho-kinases (ROCK) and eNOS.
- These proteins play critical roles in acute inflammatory responses.
Purpose of the Study:
- To investigate the protective effects of simvastatin in a rat model of hemorrhage/resuscitation (H/R).
- To elucidate the underlying mechanisms of simvastatin's action in this acute inflammation model.
Main Methods:
- Female Lewis rats were pretreated with simvastatin or vehicle for 6 days.
- Hemorrhage was induced to a mean arterial pressure of 30 mmHg for 60 minutes, followed by resuscitation.
- Tissues were harvested 2 hours post-resuscitation; mortality was assessed at 72 hours.
Main Results:
- Simvastatin pretreatment increased survival rates from 20% to 80%.
- Simvastatin reduced liver injury markers (ALT, hepatic necrosis), oxidative/nitrosative stress, and inflammation (IL-6, neutrophil infiltration).
- Simvastatin upregulated eNOS and heme oxygenase 1, while decreasing Rho-kinase activity markers.
Conclusions:
- Simvastatin pretreatment confers significant protection against H/R-induced injury in rats.
- The beneficial effects are mediated by reduced inflammation, oxidative stress, and modulation of the Rho/ROCK pathway.
- Simvastatin supports protective mechanisms crucial for hepatic microcirculation during acute inflammation.
Abstract:
Statins are established in the prevention and therapy of chronic cardiovascular diseases because of inhibition of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A), thus lowering blood cholesterol levels. However, their cholesterol-independent effects include regulation of Rho/Rho-kinases (ROCK) and eNOS, proteins centrally involved in various models of acute inflammation. Therefore, we tested the hypothesis that simvastatin confers protection after rat hemorrhage/resuscitation (H/R) and wanted to elucidate the mechanisms involved. Fifty-two female Lewis rats (180-250 g) were pretreated with simvastatin 5 mg/kg per day or vehicle for 6 days (i.p.). Then, rats were hemorrhaged to a mean arterial pressure of 30 +/- 2 mmHg for 60 min and resuscitated. Control group underwent surgical procedures without H/R. Two hours after resuscitation, tissues were harvested. Mortality was assessed 72 h after H/R. Simvastatin pretreatment increased survival after H/R from 20% to 80%. Serum alanine aminotransferase after H/R increased 2.2-fold in vehicle as compared with simvastatin-treated rats. Histopathological analysis revealed decreased hepatic necrosis in simvastatin-treated rats after H/R. Hepatic oxidative (4-hydroxynonenal) and nitrosative (3-nitrotyrosine) stress, inflammatory markers (serum IL-6 and hepatic infiltration with polymorphonuclear leukocytes), and actin cytoskeleton rearrangements were decreased after simvastatin pretreatment compared with vehicle-treated rats after H/R. Simvastatin increased eNOS and heme oxygenase 1 expression and eNOS activation. Expression of Rho/Rho-kinase and myosin phosphatase targeting subunit, Thr-MYPT1, a marker for Rho-kinase activity, decreased after simvastatin treatment compared with vehicle-treated rats after H/R. Simvastatin pretreatment exerts beneficial effects in this model of acute inflammation by supporting protective mechanisms that are important for hepatic microcirculation after H/R.
